Candel Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

NEEDHAM, Mass., June 18, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biolog

GlobeNewswireJun 18 08:00 ET

Why BioRestorative Therapies Stock Is Moving Higher Thursday

BioRestorative Therapies, Inc. (NASDAQ:BRTX) shares are trading higher Thursday after the company said it has engaged in licensing discussions with a undisclosed commercial regenerative medicine compa

BenzingaJun 13 11:52 ET

Pancreatic Cancer on the Rise: How Biotech Firms Are Developing Groundbreaking Treatments

After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may ...

PR NewswireJun 12 10:22 ET

Express News | Candel Therapeutics to Join Russell 3000® Index

ReutersJun 11 08:09 ET

Candel Therapeutics to Join Russell 3000 Index

NEEDHAM, Mass., June 11, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biolog

GlobeNewswireJun 11 08:00 ET

Retail Investors Among Candel Therapeutics, Inc.'s (NASDAQ:CADL) Largest Stockholders and Were Hit After Last Week's 20% Price Drop

Key Insights Candel Therapeutics' significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public 48% of the business is held by the top

Simply Wall StJun 8 10:46 ET